2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
58
Thoracic
18
Genitourinary
10
Head & Neck
8
Other
7
Breast
7
Lymphoid
6
Gynecologic
5
Other hematologic neoplasm
4
Plasma cell
2
Myeloid
2
Classical hematology
2
Sarcoma
1
Dermatologic
1
Conditions
Myelodysplastic Syndromes
1478
Leukemia, Myeloid, Acute
1239
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
863
Leukemia
745
Precursor Cell Lymphoblastic Leukemia-Lymphoma
704
Myeloproliferative Disorders
631
Leukemia, Myelomonocytic, Chronic
455
Lymphoma, Non-Hodgkin
447
Primary Myelofibrosis
430
Multiple Myeloma
423
Leukemia, Lymphocytic, Chronic, B-Cell
408
Hodgkin Disease
384
Lymphoma
343
Leukemia, Myeloid, Chronic-Phase
335
Blast Crisis
282
Polycythemia Vera
267
Leukemia, Myeloid, Accelerated Phase
263
Lymphoma, Follicular
254
Lymphoma, Mantle-Cell
253
Burkitt Lymphoma
246
Lymphoma, Large B-Cell, Diffuse
244
Lymphoma, B-Cell, Marginal Zone
225
Congenital Abnormalities
215
Lymphoma, Large-Cell, Immunoblastic
201
Myelodysplastic-Myeloproliferative Diseases
199
Thrombocythemia, Essential
197
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
196
Anemia, Refractory, with Excess of Blasts
194
Hematologic Neoplasms
193
Neoplasms, Plasma Cell
184
Interventions
nicotinamide-beta-riboside
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Sarcopenia
×
Myeloid
×
Clear all
NCT05194397
2025-12-04
IAMFIT
Children's Hospital of Philadelphia
Phase 2
Recruiting
80 enrolled
NCT05154474
2022-05-03
SPACE2
Weprom
Unknown
150 enrolled